Viewing Gene With Clinical Trials Data

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Report Bug Request Feature
Gene Data From HGNC: https://www.genenames.org/download/statistics-and-files/
Symbol: RAD51D
Name: RAD51 paralog D
Location: 17q12
Locus Group: protein-coding gene
Gene Type: Protein Coding
Locus Type: gene with protein product
ID+ Clinical Trials CompTox DrugMatrix Conditions Design Enrollment Locations Outcomes
Clinical Trials Data: https://classic.clinicaltrials.gov/api/gui/ref/download_all

Clinical Studies

NCT Number Status Brief Title View
NCT04190667 Homologous Recombination Deficiency Status in Epithelial Ovarian Cancer View
NCT04508803 Combination of HX008 And Niraparib in GErm-line-mutAted Metastatic Breast Cancer View
NCT04712890 Determination of Prevalence and Features of HRRm mCRPC ADAM View
NCT06033092 Low Dose TamOxifen and LifestylE Changes for bReast cANcer prevenTion View
NCT02401347 Phase II Trial of Talazoparib in BRCA12 Wild-type HER2-negative Breast Cancer and Other Solid Tumors View
NCT05033756 Comprehensive Analysis of Predictors of the Treatment With Pembrolizumab and Olaparib in Patients With Unresectable or Metastatic HER2 Negative Breast Cancer and a Deleterious Germline Mutation or a Homologous Recombination Deficiency COMPRENDO View
NCT02873975 A Study of LY2606368 Prexasertib in Patients With Solid Tumors With Replicative Stress or Homologous Repair Deficiency View
NCT03786796 Study of Olaparib in Metastatic Renal Cell Carcinoma Patients With DNA Repair Gene Mutations View
NCT05659914 Olaparib and Durvalumab MEDI4736 in Patients with Metastatic Pancreatic Cancer and DNA Damage Repair Genes Alterations View
NCT05787587 A Study of PARG Inhibitor IDE161 in Participants With Advanced Solid Tumors View
NCT05340413 Predicting Olaparib Sensitivity in Patients With Unresectable Locally AdvancedMetastatic HER2-negative Breast Cancer View
NCT04038502 Carboplatin or Olaparib for BRcA Deficient Prostate Cancer View
NCT04171700 A Study to Evaluate Rucaparib in Participants With Solid Tumors and With Deleterious Mutations in HRR Genes View
NCT02952534 A Study of Rucaparib in Patients With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency View